title: Thymic malignancy in a breast cancer patient--is there an association with anti-estrogenic effects of tamoxifen?
authors.affiliation: Department of Medical Oncology, Hacettepe University, Institute of Oncology, Ankara, Turkey. basakou@yahoo.com
authors.forename: Başak
authors.initials: B
authors.lastname: Oyan
authors.forename: Sercan
authors.initials: S
authors.lastname: Aksoy
authors.forename: Ozlem
authors.initials: O
authors.lastname: Yavas
authors.forename: Ayse
authors.initials: A
authors.lastname: Kars
authors.forename: Alev
authors.initials: A
authors.lastname: Turker
authors.forename: Ibrahim
authors.initials: I
authors.lastname: Barista
mesh_terms: D001707:Biopsy, Needle; D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D018275:Carcinoma, Lobular / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015409:Mastectomy, Radical / Q000379:methods; D008875:Middle Aged; D009367:Neoplasm Staging; D017697:Premenopause; D011879:Radiotherapy Dosage; D018570:Risk Assessment; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use; D013953:Thymus Neoplasms / Q000209:etiology / Q000532:radiotherapy / Q000556:secondary*; D016896:Treatment Outcome
chemical_list: D013629:Tamoxifen